Evidence map›Paper›PMID 31237449›Full record

ArticleAmerican journal of physiology. Endocrinology and metabolism2019

Activation of NPRs and UCP1-independent pathway following CB1R antagonist treatment is associated with adipose tissue beiging in fat-fed male dogs.

Malini S Iyer, Rebecca L Paszkiewicz, Richard N Bergman, Joyce M Richey, Orison O Woolcott, Isaac Asare-Bediako, Qiang Wu, Stella P Kim, Darko Stefanovski, Cathryn M Kolka and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Endocrinology and metabolism, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. CBInternational journal of molecular sciences · 2022
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Malini S IyerCedars-Sinai Diabetes and Obesity Research Institute, Los Angeles, California.
Rebecca L PaszkiewiczCedars-Sinai Diabetes and Obesity Research Institute, Los Angeles, California.
Richard N BergmanCedars-Sinai Diabetes and Obesity Research Institute, Los Angeles, California.
Joyce M RicheyDepartment of Physiology and Biophysics, Keck School of Medicine, University of Southern California, Los Angeles, California.
Orison O WoolcottCedars-Sinai Diabetes and Obesity Research Institute, Los Angeles, California.
Isaac Asare-BediakoCedars-Sinai Diabetes and Obesity Research Institute, Los Angeles, California.
Qiang WuCedars-Sinai Diabetes and Obesity Research Institute, Los Angeles, California.
Stella P KimCedars-Sinai Diabetes and Obesity Research Institute, Los Angeles, California.
Darko StefanovskiCedars-Sinai Diabetes and Obesity Research Institute, Los Angeles, California.
Cathryn M KolkaCedars-Sinai Diabetes and Obesity Research Institute, Los Angeles, California.ORCID 0000-0002-6636-7062
Deborah J CleggCedars-Sinai Diabetes and Obesity Research Institute, Los Angeles, California.
Morvarid KabirCedars-Sinai Diabetes and Obesity Research Institute, Los Angeles, California.
Cedars-Sinai Medical Center · USUniversity of Southern California · US

Funding

QUANTITATION OF FACTORS REGULATING GLUCOSE TOLERANCER01DK029867 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MARILYN ADER · 1986 to 2026
$11.0M
QUANTITATIVE STUDIES OF METABOLIC ORGAN DYNAMICSR01DK027619 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BERGMAN, RICHARD NATHAN · 1986 to 2022
$6.2M
Quantitative Studies of Metabolic Organ DynamicsR37DK027619 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BERGMAN, RICHARD NATHAN · 2007 to 2016
$6.2M
NIDDK NIH HHS R01 DK027619NIDDK NIH HHS R01 DK029867NIDDK NIH HHS R37 DK027619
6 · The paper itself

Abstract

CB1 receptor (CB1R) antagonism improves the deleterious effects of a high-fat diet (HFD) by reducing body fat mass and adipocyte cell size. Previous studies demonstrated that the beneficial effects of the CB1R antagonist rimonabant (RIM) in white adipose tissue (WAT) are partially due to an increase of mitochondria numbers and upregulation thermogenesis markers, suggesting an induction of WAT beiging. However, the molecular mechanism by which CB1R antagonism induces weight loss and WAT beiging is unclear. In this study, we probed for genes associated with beiging and explored longitudinal molecular mechanisms by which the beiging process occurs. HFD dogs received either RIM (HFD+RIM) or placebo (PL) (HFD+PL) for 16 wk. Several genes involved in beiging were increased in HFD+RIM compared with pre-fat, HFD, and HFD+PL. We evaluated lipolysis and its regulators including natriuretic peptide (NP) and its receptors (

Indexed as

Adipose TissueAdipose Tissue, BrownAdipose Tissue, WhiteAnimalsDiet, High-FatDogsGene ExpressionInflammationInsulin ResistanceMaleOrganelle BiogenesisReceptor, Cannabinoid, CB1Receptors, Adrenergic, betaReceptors, Atrial Natriuretic FactorRimonabantThermogenesisReceptor, Cannabinoid, CB1Receptors, Adrenergic, betaReceptors, Atrial Natriuretic FactorRimonabantUncoupling Protein 1adipose tissue beigingCB1R antagonistdogsinsulin resistance

Identifiers

PMID31237449
PMCPMC6766608
OpenAlexW2954621141

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.